Skip to main content
. 2014 Apr 25;14:70. doi: 10.1186/1471-2466-14-70

Table 1.

Baseline comparison between the study groups

Variables (measure) CG IG p
Adherence (%)
41.9
40.3
0.843*
Sex (% males)
91.9%
91.7%
0.96*
Age (years)
68.59 (66.4-70.78)
69.57 (67.74-71.4)
0.509**
Low Educational Level
81%
75%
0.683*
Current Smoking (%)
33.8%
30.6%
0.676*
Smoking history (Pack-years)
58.67 (48.68-68.66)
67.07 (55.88-78.26)
0.275**
Cigarettes/day
21.32 (19.3-23.34)
19.45 (15.87-23.03)
0.683**
BMI (Kg/m2)
31.42 (27.47-35.37)
30.11 (29.06-31.16)
0.538**
Comorbidity
 
 
 
• HBP (%)
40
58,3
0.032*
• DM (%)
25.7
38.9
0.088*
• OA (%)
33.8
29.2
0.548*
Diagnosis time (years)
4.27 (3.57-4.97)
4.61 (3.63-5.59)
0.585**
Pattern (%)
 
 
0.673*
• Obstructive
47.8
54.9
• Restrictive
13
12.7
• Mixed
39.1
32.4
Severity (%)
 
 
0.630*
• Mild
34.8
40.6
• Moderate
43,5
43,5
• Severe
21.7
15.9
Exacerbations per years
0.82 (0.59-1.05)
0.92 (0.67-1.17)
0.642**
Visits HC due COPD
1.56 (1.15-1.97)
2.04 (1.54-2.54)
0.162**
Treatment (%)
 
 
 
• Anticholinergic
77
77.8
0.914*
• Beta-2 adrenergic
79.7
80.6
0.900*
• Inhaled corticosteroids
74.3
66.7
0.310*
• Xanthine
6.8
9.7
0.514*
Number of Devices (%)
 
 
0.913*
• 1
29.7%
30.6%
• 2/more
70.3%
69.4%
SGRQ (scores)
 
 
 
Total
39.53 (35,42-43.64)
35.32 (31.35-39.29)
0.152**
• Activity
52.05 (48.12-57.98)
50.62 (45.83-55.4)
0.49**
• Symptoms
42.74 (38.14-47.34)
39.62 (35.21-44.03)
0.341**
• Impact
30.66 (26.45-34.87)
25.46 (21.41-29.51)
0.085**
EuroQoL5D-3 L (%without problem)
 
 
 
• Mobility
54.1
59.7
0.489*
• Self-care
82.4
86.1
0.542*
• Perform main, family or leisure activities
77
80.6
0.601*
• Anxious or depressed
40.5
50
0.099*
• Pain or discomfort 64.9 70.8 0.207*

Quantitative variables: mean (CI 95%); Qualitative variables: %.

CG: control group; IG: intervention group; BMI: body mass index; HBP: high blood pressure; DM: diabetes mellitus; OA: osteoarthritis HC: health center; SGRQ: Saint George Respiratory Questionnaire.

*ji-schare test; **ANOVA test.